| |
Article Title |
Author(s) |
Type (Status) |
Available Online |
|
Synthesis and evaluation of nucleoside radiotracers for imaging proliferation
DOI: 10.1016/j.nucmedbio.2011.12.002
Abstract: Introduction: Uncontrolled proliferation is a fundamental characteristic of cancer, and consequently, imaging of tumor proliferative status finds interest clinically both as a diagnostic too...
|
Graham Smith,
Roberta Sala,
Laurence Carroll,
Kevin Behan,
Matthias Glaser,
Edward Robins,
Quang-Dé Nguyen,
Eric O. Aboagye
et al.
|
Full-length article
(In Press Corrected Proof)
|
10 February 2012 |
|
Pretargeting vs. direct targeting of human betalox5 islet cells subcutaneously implanted in mice using an anti-human islet cell antibody
DOI: 10.1016/j.nucmedbio.2011.12.001
Abstract: Introduction: We previously demonstrated MORF/cMORF pretargeting of human islets and betalox 5 cells (a human beta cell line) transplanted subcutaneously in mice with the anti-human islet an...
|
Guozheng Liu,
Shuping Dou,
Ali Akalin,
Mary Rusckowski,
Philip R. Streeter,
Leonard D. Shultz,
Dale L. Greiner
et al.
|
Full-length article
(In Press Corrected Proof)
|
10 February 2012 |
|
Radiolabeled Zn-DPA as a potential infection imaging agent
DOI: 10.1016/j.nucmedbio.2011.12.006
Abstract: Introduction: A zinc-dipicolylamine analog (Zn-DPA) conjugated with a fluorophore (PSVue®794) has been shown to image bacterial infections in mice. However, radiolabeled Zn-DPA has not previ...
|
Xinrong Liu,
Dengfeng Cheng,
Brian D. Gray,
Yuzhen Wang,
Ali Akalin,
Mary Rusckowski,
Koon Y. Pak,
Donald J. Hnatowich
et al.
|
Full-length article
(In Press Corrected Proof)
|
10 February 2012 |
|
Radiation dosimetry of the translocator protein ligands [18F]PBR111 and [18F]PBR102
DOI: 10.1016/j.nucmedbio.2011.11.003
Abstract: Introduction: The translocator protein (TSPO) ligands [18F]PBR111 and [18F]PBR102 show promise for imaging neuroinflammation. Our aim was to estimate the radiation dose to humans from primat...
|
Jordan D. Verschuer,
Jocelyn Towson,
Stefan Eberl,
Andrew Katsifis,
David Henderson,
Peter Lam,
Lingfeng Wen,
Christian Loc'h,
Filomena Mattner,
Sally Thomson,
Armin Mohamed,
Michael J. Fulham
et al.
|
Full-length article
(In Press Corrected Proof)
|
02 February 2012 |
|
A fast chemoenzymatic synthesis of [11C]-N5,N10-methylenetetrahydrofolate as a potential PET tracer for proliferating cells
DOI: 10.1016/j.nucmedbio.2011.12.003
Abstract: Introduction: Thymidylate synthase and folate receptors are well-developed targets of cancer therapy. Discovery of a simple and fast method for the conversion of 11CH3Ito[11C]-formaldehyde (...
|
Muhammad Saeed,
Timothy J. Tewson,
Colbin E. Erdahl,
Amnon Kohen
|
Full-length article
(In Press Corrected Proof)
|
02 February 2012 |
|
Evaluation of 68Ga-labeled tracers for PET imaging of myocardial perfusion in pigs
DOI: 10.1016/j.nucmedbio.2011.11.007
Abstract: Purpose: We evaluated four potential gallium-68 (68Ga)-labeled tracers for positron emission tomography (PET) imaging of myocardial perfusion in comparison with oxygen-15-labeled water ([15O...
|
Miikka Tarkia,
Antti Saraste,
Tiina Saanijoki,
Vesa Oikonen,
Tommi Vähäsilta,
Marjatta Strandberg,
Christoffer Stark,
Tuula Tolvanen,
Mika Teräs,
Timo Savunen,
Mark A. Green,
Juhani Knuuti,
Anne Roivainen
et al.
|
Full-length article
(In Press Corrected Proof)
|
20 January 2012 |
|
Quantification of regional cerebral blood flow in rats using an arteriovenous shunt and micro-PET
DOI: 10.1016/j.nucmedbio.2011.11.004
Abstract: Introduction: Measurement of regional cerebral blood flow (rCBF) in rodents can provide knowledge of pathophysiology of the cerebral circulation, but generally requires blood sampling for an...
|
Takayuki Ose,
Hiroshi Watabe,
Takuya Hayashi,
Nobuyuki Kudomi,
Masaaki Hikake,
Hajime Fukuda,
Noboru Teramoto,
Yasuyoshi Watanabe,
Hirotaka Onoe,
Hidehiro Iida
et al.
|
Full-length article
(In Press Corrected Proof)
|
20 January 2012 |
|
A historical perspective on the specific activity of radiopharmaceuticals: what have we learned in the 35 years of the ISRC?
DOI: 10.1016/j.nucmedbio.2011.11.005
Abstract: Specific activity (SA), defined as the amount of radioactivity per unit mass of a compound, is arguably one of the most important parameters in radiopharmaceutical development, particularly ...
|
Suzanne E. Lapi,
Michael J. Welch
|
Review article
(In Press Corrected Proof)
|
20 January 2012 |
|
Bombesin analogues for gastrin-releasing peptide receptor imaging
DOI: 10.1016/j.nucmedbio.2011.10.009
Abstract: Objectives: The present study describes the design and development of a series of new bombesin (BBN) antagonist peptide ligands of the form [64Cu-(NO2A-X-D-Phe6-BBN(6-13)NHEt)], where Cu-64=...
|
Prasant K. Nanda,
Usha Pandey,
Brienne N. Bottenus,
Tammy L. Rold,
Gary L. Sieckman,
Ashley F. Szczodroski,
Timothy J. Hoffman,
Charles J. Smith
et al.
|
Full-length article
(In Press Corrected Proof)
|
20 January 2012 |
|
In vitro and in vivo evaluation of a 64Cu-labeled NOTA-Bn-SCN-Aoc-bombesin analogue in gastrin-releasing peptide receptor expressing prostate cancer
DOI: 10.1016/j.nucmedbio.2011.12.004
Abstract: Introduction: Bombesin (BN) is an amphibian peptide that binds to the gastrin-releasing peptide receptor (GRPR). It has been demonstrated that BN analogues can be radiolabeled for potential ...
|
Jeffrey M. Craft,
Ravindra A. De Silva,
Kimberly A. Lears,
Rebecca Andrews,
Kexian Liang,
Samuel Achilefu,
Buck E. Rogers
et al.
|
Full-length article
(In Press Corrected Proof)
|
20 January 2012 |
|
Varenicline increases in vivo striatal dopamine D2/3 receptor binding: an ultra-high-resolution pinhole [123I]IBZM SPECT study in rats
DOI: 10.1016/j.nucmedbio.2011.11.006
Abstract: Introduction: Ex vivo storage phosphor imaging rat studies reported increased brain dopamine D2/3 receptor (DRD2/3) availability following treatment with varenicline, a nicotinergic drug. Ho...
|
Cleo L. Crunelle,
Tim C. de Wit,
Kora de Bruin,
Ruud M. Ramakers,
Frans van der Have,
Freek J. Beekman,
Wim van den Brink,
Jan Booij
et al.
|
Full-length article
(In Press Corrected Proof)
|
20 January 2012 |
|
Evaluation of the relationship between [18F]FDG and P-glycoprotein expression: an experimental study
DOI: 10.1016/j.nucmedbio.2011.12.007
Abstract: Introduction: P-glycoprotein (P-gp) is a cell-membrane-associated protein that transports a variety of drug substrates. We sought to evaluate the relationship between 2-[18F]fluoro-2-deoxy-d...
|
Chunjing Yu,
Weixing Wan,
Bin Zhang,
Shengming Deng,
Tzu-Chen Yen,
Yiwei Wu
et al.
|
Full-length article
(In Press Corrected Proof)
|
20 January 2012 |
|
An automated module for the separation and purification of cyclotron-produced 99mTcO4−
DOI: 10.1016/j.nucmedbio.2011.10.006
Abstract: Introduction: The shortage of reactor-produced molybdenum-99 (99Mo, t½=66 h) has renewed interest in alternative production methods of its daughter isotope, technetium-99m (99mTc, t½=6.02 h)...
|
Thomas J. Morley,
Maurice Dodd,
Katherine Gagnon,
Vicky Hanemaayer,
John Wilson,
Stephen A. McQuarrie,
Wade English,
Thomas J. Ruth,
François Bénard,
Paul Schaffer
et al.
|
Full-length article
(In Press Corrected Proof)
|
09 January 2012 |
|
Synthesis and preliminary evaluation of [18F]-labeled 2-oxoquinoline derivatives for PET imaging of cannabinoid CB2 receptor
DOI: 10.1016/j.nucmedbio.2011.10.019
Abstract: Introduction: The cannabinoid receptor type 2 (CB2) is an important target for development of drugs and imaging agents for diseases, such as neuroinflammation, neurodegeneration and cancer. ...
|
Nashaat Turkman,
Aleksander Shavrin,
Vincenzo Paolillo,
Hsin Hsien Yeh,
Leo Flores,
Suren Soghomonian,
Brian Rabinovich,
Andrei Volgin,
Juri Gelovani,
Mian Alauddin
et al.
|
Full-length article
(In Press Corrected Proof)
|
09 January 2012 |
|
64Cu-NO2A-RGD-Glu-6-Ahx-BBN(7-14)NH2: a heterodimeric targeting vector for positron emission tomography imaging of prostate cancer
DOI: 10.1016/j.nucmedbio.2011.10.004
Abstract: Introduction: The present study describes the design and development of a new heterodimeric RGD-bombesin (BBN) agonist peptide ligand for dual receptor targeting of the form 64Cu-NO2A-RGD-Gl...
|
Andrew B. Jackson,
Prasant K. Nanda,
Tammy L. Rold,
Gary L. Sieckman,
Ashley F. Szczodroski,
Timothy J. Hoffman,
Xiaoyuan Chen,
Charles J. Smith
et al.
|
Full-length article
(In Press Corrected Proof)
|
09 January 2012 |
|
Synthesis, radiolabeling, biodistribution and fluorescent imaging of histidine-coupled hematoporphyrin
DOI: 10.1016/j.nucmedbio.2011.10.010
Abstract: Introduction: Hematoporphyrin (Hp) and hematoporphyrin derivatives (HpDs) have been widely used as photosensitizers in photodynamic therapy (PDT). Radiolabeling of HpDs is helpful for precli...
|
Yupeng Liu,
Bo Shen,
Fei Liu,
Bin Zhang,
Taiwei Chu,
Jing Bai,
Shanglian Bao
et al.
|
Full-length article
(In Press Corrected Proof)
|
09 January 2012 |
|
Preclinical studies of potential amyloid binding PET/SPECT ligands in Alzheimer's disease
DOI: 10.1016/j.nucmedbio.2011.10.007
Abstract: Visualizing the neuropathological hallmarks amyloid plaques and neurofibrillary tangles of Alzheimer's disease in vivo using positron emission tomography (PET) or single photon emission comp...
|
Marie M. Svedberg,
Obaidur Rahman,
Håkan Hall
|
Review article
(In Press Corrected Proof)
|
09 January 2012 |
|
Synthesis and preclinical evaluation of [11C]D617, a metabolite of (R)-[11C]verapamil
DOI: 10.1016/j.nucmedbio.2011.10.017
Abstract: Objectives: (R)-[11C]verapamil is widely used as a positron emission tomography (PET) tracer to evaluate P-glycoprotein (P-gp) functionality at the blood–brain barrier in man. A disadvantage...
|
Joost Verbeek,
Stina Syvänen,
Robert C. Schuit,
Jonas Eriksson,
Elizabeth C. de Lange,
Albert D. Windhorst,
Gert Luurtsema,
Adriaan A. Lammertsma
et al.
|
Full-length article
(In Press Corrected Proof)
|
09 January 2012 |
|
Authors' reply to letter to the editor by Robert Freudenberg
DOI: 10.1016/j.nucmedbio.2011.10.014
Thank you for your interest in our recent article .
|
Bok-Nam Park,
Wooyoung Shim,
Gwang Lee,
Oh Young Bang,
Young-Sil An,
Joon-Kee Yoon,
Young Hwan Ahn
et al.
|
Correspondence
(In Press Corrected Proof)
|
15 December 2011 |
|
Evaluation of an automated double-synthesis module: efficiency and reliability of subsequent radiosyntheses of FHBG and FLT
DOI: 10.1016/j.nucmedbio.2011.10.018
Abstract: We optimized the synthesis methods for 3′-deoxy-3′-[18F]fluorothymidine ([18F]FLT) and 9-(4-[18F]fluoro-3-[hydroxymethyl]butyl)guanine) ([18F]FHBG) and automated them on an Explora General N...
|
Sabrina Niedermoser,
Manuela Pape,
Franz Josef Gildehaus,
Carmen Wängler,
Markus Hartenbach,
Ralf Schirrmacher,
Peter Bartenstein,
Björn Wängler
et al.
|
Full-length article
(In Press Corrected Proof)
|
15 December 2011 |
|
11C-CHO PET in optimization of target volume delineation and treatment regimens in postoperative radiotherapy for brain gliomas
DOI: 10.1016/j.nucmedbio.2011.10.003
Abstract: Objective: We explored the clinical values of 11C-choline (11C-CHO) PET in optimization of target volume delineation and treatment regimens in postoperative radiotherapy for brain gliomas. M...
|
Fang-Ming Li,
Qing Nie,
Rui-Min Wang,
Susan M. Chang,
Wen-Rui Zhao,
Qi Zhu,
Ying-Kui Liang,
Ping Yang,
Jun Zhang,
Hai-Wei Jia,
Heng-Hu Fang
et al.
|
Full-length article
(In Press Corrected Proof)
|
15 December 2011 |
|
Combined-modality radioimmunotherapy: synergistic effect of paclitaxel and additive effect of bevacizumab
DOI: 10.1016/j.nucmedbio.2011.10.020
Abstract: Introduction: This study was undertaken to investigate the effect of paclitaxel and bevacizumab on the therapeutic efficacy of 90Y-labeled B3 monoclonal antibody, directed against Ley antige...
|
Beom-Su Jang,
Sang-Myung Lee,
Hyung Sub Kim,
In Soo Shin,
Faezeh Razjouyan,
Shutao Wang,
Zhengsheng Yao,
Ira Pastan,
Matthew R. Dreher,
Chang H. Paik
et al.
|
Full-length article
(In Press Corrected Proof)
|
15 December 2011 |
|
An allogenic site-specific rat model of bone metastases for nuclear medicine and experimental oncology
DOI: 10.1016/j.nucmedbio.2011.10.008
Abstract: Bone metastases are a major problem in several tumor entities affecting the therapeutic decision and the patient's prognosis. Single photon emission computed tomography (SPECT) and positron ...
|
Barbara Biesalski,
Bengü Yilmaz,
Hans-Georg Buchholz,
Nicole Bausbacher,
Mathias Schreckenberger,
Oliver Thews
et al.
|
Full-length article
(In Press Corrected Proof)
|
15 December 2011 |
|
Preclinical evaluation of anti-HER2 Affibody molecules site-specifically labeled with 111In using a maleimido derivative of NODAGA
DOI: 10.1016/j.nucmedbio.2011.10.013
Abstract: Introduction: Affibody molecules have demonstrated potential for radionuclide molecular imaging. The aim of this study was to synthesize and evaluate a maleimido derivative of the 1,4,7-tria...
|
Mohamed Altai,
Anna Perols,
Amelie Eriksson Karlström,
Mattias Sandström,
Frederic Boschetti,
Anna Orlova,
Vladimir Tolmachev
et al.
|
Full-length article
(In Press Corrected Proof)
|
15 December 2011 |
|
In vitro and in vivo evaluation of selected 68Ga-siderophores for infection imaging
DOI: 10.1016/j.nucmedbio.2011.09.012
Abstract: Introduction: Siderophores are low-molecular-mass iron chelators serving as iron transporters for almost all bacteria, fungi and some plants. Iron is an essential element for majority of org...
|
Milos Petrik,
Hubertus Haas,
Markus Schrettl,
Anna Helbok,
Michael Blatzer,
Clemens Decristoforo
et al.
|
Full-length article
(In Press Corrected Proof)
|
15 December 2011 |
|
Influence of cations on the complexation yield of DOTATATE with yttrium and lutetium: a perspective study for enhancing the 90Y and 177Lu labeling conditions
DOI: 10.1016/j.nucmedbio.2011.10.015
Abstract: The DOTA macrocyclic ligand can form stable complexes with many cations besides yttrium and lutetium. For this reason, the presence of competing cationic metals in yttrium-90 and lutetium-17...
|
Mattia Asti,
Matteo Tegoni,
Daniela Farioli,
Michele Iori,
Claudio Guidotti,
Cathy S. Cutler,
Pat Mayer,
Annibale Versari,
Diana Salvo
et al.
|
Full-length article
(In Press Corrected Proof)
|
15 December 2011 |
|
68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers
DOI: 10.1016/j.nucmedbio.2011.10.011
Abstract: Introduction: The urokinase-type plasminogen activator receptor (uPAR) is a well-established biomarker for tumor aggressiveness and metastatic potential. DOTA-AE105 and DOTA-AE105-NH2 labele...
|
Morten Persson,
Jacob Madsen,
Søren Østergaard,
Michael Ploug,
Andreas Kjaer
et al.
|
Full-length article
(In Press Corrected Proof)
|
15 December 2011 |
|
Synthesis of oncological [11C]radiopharmaceuticals for clinical PET
DOI: 10.1016/j.nucmedbio.2011.10.016
Abstract: Positron emission tomography (PET) is a nuclear medicine modality which provides quantitative images of biological processes in vivo at the molecular level. Several PET radiopharmaceuticals ...
|
Filippo Lodi,
Claudio Malizia,
Paolo Castellucci,
Gianfranco Cicoria,
Stefano Fanti,
Stefano Boschi
et al.
|
Review article
(In Press Corrected Proof)
|
15 December 2011 |
|
Initial evaluation in healthy humans of [18F]DPA-714, a potential PET biomarker for neuroinflammation
DOI: 10.1016/j.nucmedbio.2011.10.012
Abstract: Introduction: The translocator protein 18 kDa (TSPO), although minimally expressed in healthy brain, is up-regulated in pathological conditions, coinciding with microglial activation. It is ...
|
Nicolas Arlicot,
Johnny Vercouillie,
Maria-João Ribeiro,
Clovis Tauber,
Yann Venel,
Jean-Louis Baulieu,
Serge Maia,
Philippe Corcia,
Michael G. Stabin,
Aaron Reynolds,
Michael Kassiou,
Denis Guilloteau
et al.
|
Full-length article
(In Press Corrected Proof)
|
15 December 2011 |
|
Synthesis, radioiodination and in vitro and in vivo sigma receptor studies of N-1-allyl-N´-4-phenethylpiperazine analogs
DOI: 10.1016/j.nucmedbio.2011.10.001
Abstract: Introduction: Sigma-1 (σ1) receptor radioligands are useful for basic pharmacology studies and for imaging studies in neurology, psychiatry and oncology. We derived a hybrid structure, N-1-a...
|
Susan Z. Lever,
Rong Xu,
Kuo-Hsien Fan,
Emily A. Fergason-Cantrell,
Terry L. Carmack,
Lisa D. Watkinson,
John R. Lever
et al.
|
Full-length article
(In Press Corrected Proof)
|
15 December 2011 |
|
Simple preparation and purification of ethanol-free solutions of 3′-deoxy-3′-[18F]fluorothymidine by means of disposable solid-phase extraction cartridges
DOI: 10.1016/j.nucmedbio.2011.10.005
Abstract: Introduction: 3′-Deoxy-3′-[18F]fluorothymidine ([18F]FLT) shows great potential as a tracer for proliferative studies with PET. However, its regular application is often limited by low radio...
|
Claudio Pascali,
Anna Bogni,
Lorenza Fugazza,
Claudio Cucchi,
Ornella Crispu,
Luca Laera,
Ren Iwata,
Greta Maiocchi,
Flavio Crippa,
Emilio Bombardieri
et al.
|
Full-length article
(In Press Corrected Proof)
|
15 December 2011 |
|
Measuring diffuse metabolic activity on FDG-PET/CT: new method for evaluating Langerhans cell histiocytosis activity in pulmonary parenchyma
DOI: 10.1016/j.nucmedbio.2011.10.002
Abstract: Introduction: Pulmonary Langerhans cell histiocytosis (PLCH) is a rare cause of interstitial lung disease characterized by formation of nodules in the active phase of the disease that evolve...
|
Petr Szturz,
Zdeněk Řehák,
Renata Koukalová,
Zdeněk Adam,
Marta Krejčí,
Luděk Pour,
Lenka Zahradová,
Jiří Vaníček,
Tomáš Nebeský,
Roman Hájek,
Jiří Mayer
et al.
|
Full-length article
(In Press Corrected Proof)
|
15 December 2011 |
|
Dosimetry of 99mTc-HMPAO in mesenchymal stem cells
DOI: 10.1016/j.nucmedbio.2011.09.011
We read the article by Park et al. with great interest. The authors describe a method of using bone marrow mesenchymal stem cells (BMSCs) labeled with 99mTc-HMPAO to evaluate acute brain trauma in ra...
|
Robert Freudenberg,
Jörg Kotzerke
|
Correspondence
(In Press Corrected Proof)
|
12 December 2011 |
|
Preclinical evaluation of [11C]NE40, a type 2 cannabinoid receptor PET tracer
DOI: 10.1016/j.nucmedbio.2011.09.005
Abstract: Introduction: Up-regulation of the type 2 cannabinoid receptor (CB2R) has been reported in (neuro)inflammatory diseases. In this study, we report the preclinical evaluation of [11C]NE40 as p...
|
Nele Evens,
Caroline Vandeputte,
Charlotte Coolen,
Peter Janssen,
Raf Sciot,
Veerle Baekelandt,
Alfons M. Verbruggen,
Zeger Debyser,
Koen Van Laere,
Guy M. Bormans
et al.
|
Full-length article
(In Press Corrected Proof)
|
12 December 2011 |
|
Difficulties in dopamine transporter radioligand PET analysis: the example of LBT-999 using [18F] and [11C] labelling: Part II: Metabolism studies
DOI: 10.1016/j.nucmedbio.2011.09.006
Abstract: Introduction: LBT-999, (E)-N-(4-fluorobut-2-enyl)-2β-carbomethoxy-3β-(4'-tolyl)nortropane, has been developed for PET imaging of the dopamine transporter. [18F]LBT-999 PET studies in baboons...
|
Marie-Anne Peyronneau,
Wadad Saba,
Frédéric Dollé,
Sébastien Goutal,
Christine Coulon,
Michel Bottlaender,
Héric Valette
et al.
|
Full-length article
(In Press Corrected Proof)
|
12 December 2011 |
|
Preclinical evaluation of a 68Ga-labeled biotin analogue for applications in islet transplantation
DOI: 10.1016/j.nucmedbio.2011.09.009
Abstract: Introduction: Islet transplantation is a promising treatment for type 1 diabetes mellitus, but the fate of the cells after intraportal infusion is unclear. It is therefore imperative to deve...
|
Olof Eriksson,
Fredrik Carlsson,
Elisabeth Blom,
Anders Sundin,
Bengt Långström,
Olle Korsgren,
Irina Velikyan
et al.
|
Full-length article
(In Press Corrected Proof)
|
02 December 2011 |
|
Evaluation of 111In-labeled macrocyclic chelator-amino acid derivatives for cancer imaging
DOI: 10.1016/j.nucmedbio.2011.09.010
Abstract: Purpose: We evaluated new 111In-labeled amino acid derivatives, in which the amino acids are conjugated with1,4,7,10-tetra-azacyclododecane-1,4,7,10-tetraacetic acid (DOTA), 1,4,7,10-tetraaz...
|
Jong Jin Lee,
Dinesh Shetty,
Yun-Sang Lee,
Sang Eun Kim,
Young Joo Kim,
Mi Kyung Hong,
Ji Yeon Son,
Jae Min Jeong
et al.
|
Full-length article
(In Press Corrected Proof)
|
02 December 2011 |
|
Fluorine-18 labeling of three novel d-peptides by conjugation with N-succinimidyl-4-[18F]fluorobenzoate and preliminary examination by postmortem whole-hemisphere human brain autoradiography
DOI: 10.1016/j.nucmedbio.2011.09.008
Abstract: Introduction: β-Amyloid (Aβ) plaques and neurofibrillary tangles are the main characteristics of Alzheimer's disease (AD). Positron emission tomography (PET), a high-resolution, sensitive, a...
|
Mahabuba Jahan,
Sangram Nag,
Raisa Krasikova,
Urs Weber,
Andreas Muhs,
Andrea Pfeifer,
Christian Spenger,
Dieter Willbold,
Balázs Gulyás,
Christer Halldin
et al.
|
Full-length article
(In Press Corrected Proof)
|
02 December 2011 |
|
Insights into the failure of the potential, neutral myocardial imaging agent TcN-NOET: physicochemical identification of by-products and degradation species
DOI: 10.1016/j.nucmedbio.2011.09.007
Abstract: Introduction: The neutral complex [99mTc(N)(NOEt)2], often referred to as TcN-NOET [NOEt=N-ethoxy,N-ethyldithiocarbamate(1−)], was proposed several years ago as a myocardial imaging agent. D...
|
Francesco Tisato,
Cristina Bolzati,
Fiorenzo Refosco,
Marina Porchia,
Roberta Seraglia,
Davide Carta,
Roberto Pasqualini
et al.
|
Full-length article
(In Press Corrected Proof)
|
02 December 2011 |
|
Study of [18F]FLT and [123I]IaraU for cellular imaging in HSV1 tk-transfected murine fibrosarcoma cells: evaluation of the tracer uptake using 5-fluoro, 5-iodo and 5-iodovinyl arabinosyl uridines as competitive probes
DOI: 10.1016/j.nucmedbio.2011.09.003
Abstract: As one of the most intensively studied probes for imaging of the cellular proliferation, [18F]FLT was investigated whether the targeting specificity of thymidine kinase 1 (TK1) dependency co...
|
Ho-Lien Huang,
Li-Wu Chiang,
Jia-Rong Chen,
Wen K. Yang,
Kee-Ching Jeng,
Jenn-Tzong Chen,
Ting-Shien Duh,
Wuu-Jyh Lin,
Shiou-Shiow Farn,
Chi-Shiun Chiang,
Chia-Wen Huang,
Kun-I Lin,
Chung-Shan Yu
et al.
|
Full-length article
(In Press Corrected Proof)
|
30 November 2011 |
|
Combination of nitric oxide stimulation with high-dose 18F-FDG promotes apoptosis and enhances radiation therapy of endothelial cells
DOI: 10.1016/j.nucmedbio.2011.09.004
Abstract: Introduction: High-dose 18F-FDG can provide targeted nuclear therapy of cancer. Endothelial cell injury is a key determinant of tumor response to radiotherapy. Here, we tested the hypothesis...
|
Jin-Young Paik,
Jin-Won Park,
Kyung-Ho Jung,
Eun Jeong Lee,
Kyung-Han Lee
et al.
|
Full-length article
(In Press Corrected Proof)
|
14 November 2011 |